Pew-Supported Scientists Shed Light on Hepatitis C

Pew-Supported Scientists Shed Light on Hepatitis C

Matthew Evans, a 2010 Pew biomedical scholar, has led a research effort revealing new information on the hepatitis C virus, or HCV, a liver disease that affects more than 3 million people in the United States.

The study, published in Nature Communications, demonstrated how HCV becomes resistant to antiviral treatments. In addition—and with assistance from Arvin Dar,* a Pew-Stewart Scholar for Cancer Research—the investigation shed light on the link between the virus and cancer.

“There is a critical need for more weapons in our arsenal to fight HCV—particularly for affordable, effective treatment as we try to stay a step ahead of this virus and prevent it from developing the kind of drug resistance we’re seeing in the bacterial realm,” Evans said in a press release.

The research team explored HCV’s response to an experimental treatment that cut off the supply of a certain molecule that the virus uses to infect cells. They found, contrary to their expectations, that the treatment triggered the emergence of drug-resistant viral strains that could infect cells with only small amounts of the molecule. This finding could help clinicians determine the best treatment options for patients affected by the virus.

They also discovered that HCV decreased the activity of the same molecule, which acts as a tumor suppressor in the liver. Future studies that build upon this work could pinpoint the precise way the virus leads to the development of cancer and inform new interventions to prevent it.

*The Pew-Stewart Scholars for Cancer Research is a national initiative funded by the Alexander and Margaret Stewart Trust and administered by Pew to support promising early-career scientists whose research will accelerate discovery and advance progress to a cure for cancer.

The front facade of the Supreme Court of the United States in Washington, DC.

Agenda for America

A collection of resources to help federal, state, and local decision-makers set an achievable agenda for all Americans

Quick View

Data-driven policymaking is not just a tool for finding new solutions for emerging challenges, it makes government more effective and better able to serve the public interest. In the coming months, President Joe Biden and the 117th Congress will tackle a number of environmental, health, public safety, and fiscal and economic issues—nearly all of them complicated by the COVID-19 pandemic. To help solve specific, systemic problems in a nonpartisan fashion, Pew has compiled a series of briefings and recommendations based on our research, technical assistance, and advocacy work across America.


States of Innovation

Data-driven state policy innovations across America

Quick View

Data-driven policymaking is not just a tool for finding new solutions for difficult challenges. When states serve their traditional role as laboratories of innovation, they increase the American people’s confidence that the government they choose—no matter the size—can be effective, responsive, and in the public interest.